Biophytis SABiophytis SA - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

The report of Biophytis SA leverages intelligence from across the web as well as from available filings by Biophytis SA. This webpage is a zero-cost E,S&G assessment for Biophytis SA. Scroll down to the end of this page for potential risks for Biophytis SA based on sector, geography and marketcap.

Biophytis SA in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.0; made up of an environmental score of 6.0, social score of 8.0 and governance score of 6.9.

SDG Transparency Score for Biophytis SA 
Low
0 - 3
Medium
4 - 6

7.0

High Impact
7 - 10
Last Score Update: 2023-07-01
What drives the score for Biophytis SA 
6.0

Environmental

8.0

Social

6.9

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
326Xencor Inc
7.1
High
326iCo Therapeutics Inc
7.1
High
355Biophytis SA
7.0
High
355Agile Therapeutics Inc
7.0
High
355Antisense Therapeutics Ltd
7.0
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Biophytis SA have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Biophytis SA disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Biophytis SA report the average age of the workforce?

LockedSign up for free to unlock

Does Biophytis SA reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Biophytis SA disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Biophytis SA disclose cybersecurity risks?

LockedSign up for free to unlock

Does Biophytis SA offer flexible work?

LockedSign up for free to unlock

Does Biophytis SA have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Biophytis SA disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Biophytis SA conduct supply chain audits?

LockedSign up for free to unlock

Does Biophytis SA disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Biophytis SA conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Biophytis SA disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Biophytis SA disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Biophytis SA disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Biophytis SA disclose water use targets?

LockedSign up for free to unlock

Does Biophytis SA have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Biophytis SA have a product recall in the last two years?

LockedSign up for free to unlock

Does Biophytis SA disclose incidents of discrimination?

LockedSign up for free to unlock

Does Biophytis SA allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Biophytis SA issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Biophytis SA disclose parental leave metrics?

LockedSign up for free to unlock

Does Biophytis SA disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Biophytis SA disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Biophytis SA disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Biophytis SA support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Biophytis SA disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Biophytis SA reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Biophytis SA involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Biophytis SA disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Biophytis SA disclose its waste policy?

LockedSign up for free to unlock

Does Biophytis SA report according to TCFD requirements?

LockedSign up for free to unlock

Does Biophytis SA disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Biophytis SA disclose energy use targets?

LockedSign up for free to unlock

Does Biophytis SA disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Biophytis SA have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Biophytis SA
These potential risks are based on the size, segment and geographies of the company.

Biophytis SA, a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases and the treatment of severe respiratory failure in patients suffering from COVID-19. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract the effects of the multiple biological and environmental stresses that lead to age-related diseases. The company's lead drug candidate, Sarconeos (BIO101), is an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and Duchenne muscular dystrophy (DMD). Its second drug candidate, Macuneos (BIO201), is an orally administered small molecule in development for the treatment of retinal diseases, including dry ager elated macular degeneration (AMD) and Stargardt disease. Biophytis SA has a collaboration agreement with AFM-Telethon for the development of its Sarconeos (BIO101) for the treatment of DMD. The company was incorporated in 2006 and is based in Paris, France.

Sorry!

Failed to process!